Glucocorticosteroid therapy as predisposing factor for pulmonary sarcoidosis relapse

Conclusion: CS therapy is a risk factor for sarcoidosis relapse. Therefore, despite their high efficacy, corticosteroids are recommended in asymptomatic patients only in cases of progressive disease or lack of improvement after 3 months follow-up period.

http://erj.ersjournals.com/cgi/content/short/52/suppl_62/PA3006?rss=1

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Merenkova, I., Dziublyk, Y., Gumeniuk, G., Gumeniuk, M. Tags: Sarcoidosis and other granulomatous ILD/DPLD Source Type: research